1. 143TiPIMpower110: Phase III trial of 1L atezolizumab in PD-L1–selected chemotherapy-naive NSCLC. (3rd April 2017) Authors: Jassem, J.; de Marinis, F.; Spigel, D.R.; Lam, S.; Mocci, S.; Sandler, A.; Lopez-Chavez, A.; Deng, Y.; Giaccone, G.; Herbst, R.S. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function. (27th September 2016) Authors: Choi, M.; Kadara, H.; Zhang, J.; Parra, E.R.; Rodriguez-Canales, J.; Gaffney, S.G.; Zhao, Z.; Behrens, C.; Fujimoto, J.; Chow, C.; Kim, K.; Kalhor, N.; Moran, C.; Rimm, D.; Swisher, S.; Gibbons, D.L.; Heymach, J.; Kaftan, E.; Townsend, J.P.; Lynch, T.J. Journal: Annals of oncology Issue: Volume 28:Number 1(2017) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The value of interventional radiology in clinical trial teams: experience from the BATTLE lung cancer trials. Issue 2 (February 2021) Authors: Tam, A.L.; Papadimitrakopoulou, V.; Wistuba, I.I.; Lee, J.J.; Ensor, J.E.; Kim, E.S.; Kalhor, N.; Blumenschein, G.R.; Tsao, A.S.; Heymach, J.V.; Herbst, R.S.; Hicks, M.E.; Hong, W.K.; Gupta, S. Journal: Clinical radiology Issue: Volume 76:Issue 2(2021) Page Start: 155.e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗